Navigation Links
Quanterix Appoints Paul Chapman as President and Chief Executive Officer
Date:7/20/2012

LEXINGTON, Mass., July 20, 2012 /PRNewswire/ -- Quanterix Corporation, developer of the Single Molecule Array (Simoa) technology, announced today that it has appointed Paul Chapman as its new President and Chief Executive Officer.  Mr. Chapman joins the company at a pivotal time, as it moves from development to commercialization of its revolutionary digital ELISA platform that improves conventional immunoassay sensitivity 1000-fold.

"Quanterix's Simoa technology has the potential to dramatically change the world of biomarker research and clinical diagnostics," says Chapman.   "I am very excited to work with the exceptional team at Quanterix to make that potential a reality in the near future."

Prior to joining Quanterix, Mr. Chapman was Vice President of the BioPharm Process Solutions business at EMD Millipore where he was responsible for the Marketing and R&D teams in the $800 million business.   Prior to joining Millipore, he was the Vice President, Hospital Solutions for Roche Near Patient Testing in Austria, where he held P&L responsibility for Roche's decentralized Cardiac, Blood Gas / Electrolyte and Hospital Glucose businesses.  Mr. Chapman was also the International Business Development Manager at Roche Molecular Diagnostics for blood screening and, prior to that, held an array of sales and marketing positions at Roche Diagnostics Canada (where he began his career in 1993) focused primarily in the Molecular Diagnostics field.  Mr Chapman has a B.Sc. in Microbiology from the University of Western Ontario, a B.Sc (hons) in Immunology from the University of Guelph Ontario, and graduated from the Marketing Management Program (MMP) from the Richard Ivy School of Business.

"Paul is a visionary leader with a strong track record in several businesses and I have great confidence that he will make Quanterix a huge success," says Martin Madaus, Executive Chairman of the Board of Directors. "His background and capabilities to bring new technologies to market successfully make him uniquely qualified for Quanterix."  

Dr. Martin Madaus, who was previously CEO and Executive Chairman of the Board of Directors, will continue at Quanterix as the Executive Chairman, while Mr. Chapman takes the reins of the company's operations as President and Chief Executive Officer to prepare the organization for the launch of its first product in 2013. 

About Quanterix

Quanterix is a developer of ground-breaking tools in high definition diagnostics. Its Simoa platform uses single molecule measurements to access previously undetectable proteins. With this unprecedented sensitivity and full automation, Simoa offers significant benefits to both research and clinical testing applications. Quanterix was established in 2007 and is located in Lexington, Massachusetts.


'/>"/>
SOURCE Quanterix Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Conatus Pharmaceuticals Appoints Daniel Ripley As Head Of Corporate Development
2. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
3. C3i Appoints Jonathan Song to Business Development Executive in Asia
4. Organovo Holdings Appoints James T. Glover to Board of Directors
5. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
6. ReShape Medical Appoints Robert E. Grant to Board of Directors
7. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
8. Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
9. Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz
10. GenVec Appoints Cynthia Collins as President and CEO
11. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... (PRWEB) , ... February 19, ... ... lab notebook platform for research data management, has released a new ... research data management features. With a ‘Quick View’ of supported DNA files, ...
(Date:2/15/2020)... MIAMI and FT. LAUDERDALE, Fla. (PRWEB) , ... February 14, 2020 ... ... Lauderdale area, has joined the esteemed Haute Beauty Network. , The Haute Beauty Network, ... present Dr. Ray Lopez as a foot and ankle and our newest addition to ...
(Date:2/14/2020)... ... February 14, 2020 , ... Dignitana AB , world leader in scalp ... on to sponsor three signature events in 2020 with Susan G. Komen®. The sponsorship ... Race for the Cure® and MORE THAN PINK Walk® events in key Dignitana markets ...
Breaking Medicine Technology:
(Date:2/20/2020)... ... February 20, 2020 , ... R3 Medical Training announced its next joint injection ... how to perform injections for all large and small joints along with ultrasound needle ... videos. The best opportunity is to perform injections in a supervised setting. R3 Medical ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... at Advanced Periodontics and Dental Implant Center of Connecticut, celebrate 30 years of ... patients with the same low fees that they charged in 1989, only thirty ...
(Date:2/19/2020)... NEEDHAM, Mass. (PRWEB) , ... February 19, 2020 ... ... improve the quality and consistency of healthcare delivery, announced that it will participate ... 13, 2020, in Orlando, Florida. BPM+ Health will engage healthcare professionals and other ...
(Date:2/16/2020)... ... , ... Canadian digital healthcare portal Ask The Doctor has launched ... the Coronavirus. , "It is our duty and it is our responsibility to help ... Prakash Chand, CEO of Ask The Doctor. , Doctors and nurses around the globe ...
(Date:2/14/2020)... ... 14, 2020 , ... The Dr. Oz Show is an American daytime television ... and medical information. As an upcoming guest on the show, New York City ... in-depth medical knowledge. During the segment, Dr. Linkov, a leader and trusted authority on ...
Breaking Medicine News(10 mins):